Royce & Associates LP Sells 15,205 Shares of Innospec Inc. $IOSP

Royce & Associates LP reduced its stake in shares of Innospec Inc. (NASDAQ:IOSP – Free Report) by 4.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 293,521 shares of the specialty chemicals company’s stock after selling 15,205 shares during the period. Royce & Associates LP’s holdings in Innospec were worth $27,978,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Root Financial Partners LLC purchased a new position in shares of Innospec in the 3rd quarter valued at about $30,000. Meeder Asset Management Inc. acquired a new stake in shares of Innospec in the second quarter valued at about $36,000. State of Wyoming acquired a new stake in shares of Innospec in the third quarter valued at about $46,000. Farther Finance Advisors LLC boosted its holdings in Innospec by 94.0% during the third quarter. Farther Finance Advisors LLC now owns 675 shares of the specialty chemicals company’s stock worth $64,000 after buying an additional 327 shares in the last quarter. Finally, Public Employees Retirement System of Ohio purchased a new stake in Innospec during the second quarter worth about $62,000. 96.64% of the stock is owned by institutional investors and hedge funds.

Innospec Stock Performance

IOSP opened at $80.39 on Monday. The business’s fifty day moving average is $93.84 and its two-hundred day moving average is $84.55. The company has a market cap of $1.98 billion, a price-to-earnings ratio of 14.18, a PEG ratio of 3.20 and a beta of 0.88. Innospec Inc. has a one year low of $65.51 and a one year high of $102.00.

Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The specialty chemicals company reported $1.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.03. Innospec had a return on equity of 9.36% and a net margin of 7.49%. The business had revenue of $473.60 million during the quarter, compared to analysts’ expectations of $479.17 million. During the same quarter last year, the business posted $1.12 earnings per share. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, analysts predict that Innospec Inc. will post 5.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

IOSP has been the topic of several recent analyst reports. Weiss Ratings lowered shares of Innospec from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, November 4th. Seaport Research Partners reaffirmed a “buy” rating and issued a $110.00 target price on shares of Innospec in a report on Thursday, August 6th. Zacks Research downgraded shares of Innospec from a “hold” rating to a “strong sell” rating in a research report on Monday, November 9th. Finally, Wall Street Zen lowered Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 26th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Innospec presently has an average rating of “Reduce”.

Read Our Latest Stock Report on Innospec

Insider Activity at Innospec

In other Innospec news, Director Leslie Parrette acquired 345 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The shares were acquired at an average cost of $79.69 per share, for a total transaction of $27,493.05. Following the transaction, the director directly owned 7,721 shares of the company’s stock, valued at approximately $615,286.49. This represents a 4.68% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.45% of the stock is owned by corporate insiders.

Innospec Company Profile

(Free Report)

Innospec Inc. is a global specialty chemicals company that develops and manufactures products for customers in the fuels, oilfield and performance chemicals markets. Its Fuel Specialties business supplies additives for fuels and lubricants, while its Oilfield Services business provides chemical products and services used in oil and gas operations. Through its Performance Chemicals business, Innospec makes specialty ingredients for applications including personal care, home care and agriculture. Its products are used by industrial and consumer-products manufacturers around the world.

Further Reading

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.